Guangdong Hengrui Pharmaceutical Co., Ltd

This study is testing whether an experimental drug called HRS-9813 can slow the progression of pulmonary fibrosis, a condition where lung tissue becomes scarred and stiff. Researchers will compare the drug against a placebo in 270 adults with either idiopathic pulmonary fibrosis …

This study is testing a new injection called SHR-3045 to see if it can safely reduce disease activity in adults with moderate to severe rheumatoid arthritis. It is for people whose current treatments are not working well enough. Participants will receive either the new injection …

This study is testing an investigational drug called SHR-1703 for people with eosinophilic granulomatosis with polyangiitis (EGPA), a rare disease where the immune system attacks the body's own blood vessels. The main goal is to see if the drug can help patients achieve remission…

This study is testing an investigational drug called SHR-1703, given as multiple injections under the skin, to see if it is safe and effective for long-term use in adults with a specific type of severe asthma (eosinophilic asthma). Researchers will enroll about 200 participants w…

This study is testing whether a new injectable medication called SHR-1905 can safely reduce the size of nasal polyps and improve symptoms like congestion and loss of smell in adults with chronic sinusitis. It will compare the drug against a placebo (inactive) injection in about 2…

This study is testing an investigational injection called SHR-1819 to see if it can safely reduce the skin rash and severe itching caused by moderate-to-severe atopic dermatitis (eczema). About 200 adult participants will be randomly assigned to receive either the study drug or a…

This study is testing an investigational drug called SHR-1703 for people with a severe type of asthma driven by high levels of white blood cells called eosinophils. It aims to see if the drug can reduce the number of serious asthma attacks (exacerbations) and improve lung functio…

This early-stage study is checking the safety and how the body processes a new inhaler medication called HRS-9821. It will test a single dose in 160 healthy volunteers and multiple doses in people with COPD. The main goal is to see what side effects occur and how the drug moves t…

This study is testing whether an experimental injection called SHR-2173 can help control kidney damage in people with active lupus nephritis. About 51 participants will receive either the drug or a placebo to compare how well it reduces protein in urine and improves kidney respon…

This is the first study in people to test a new drug called SHR-2173 for adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, causing a risk of bleeding. The main goal is to check if the injection is safe and well-tolerated. Researcher…

This study is testing an experimental drug called SHR-1139 in adults with moderate-to-severe ulcerative colitis, a chronic inflammatory bowel disease. It aims to see if the drug can reduce symptoms and improve gut healing over a 60-week period. The trial is for people who haven't…

This large, late-stage study is testing whether an investigational medicine called SHR-1905 can help adults whose severe asthma is not well-controlled by current standard medications. The main goal is to see if the treatment safely reduces the yearly rate of serious asthma flare-…

This study is testing whether an experimental injection called SHR-1905 can safely reduce the severity of moderate-to-severe eczema (atopic dermatitis). About 75 adults with this chronic skin condition will receive either the real injection or a placebo to compare results. Resear…

This study is testing an investigational injection called SHR-2173 in adults with primary membranous nephropathy, a serious autoimmune kidney disease. The main goals are to see if the treatment is safe and if it helps patients achieve a positive response, which could mean reducin…

This study is testing an investigational injection called SHR-1819 to see if it safely reduces stuffy, runny, and itchy noses in adults with seasonal allergies (hay fever). It will involve about 100 participants whose symptoms are not well-controlled by standard allergy medicatio…

This is a very early, first-in-human study to check if a new potential drug called SHR-3045 is safe and how it behaves in the body. It will be given as a single injection to 16 healthy volunteers, not people with rheumatoid arthritis. The main goal is to see what side effects mig…